Product Code: RP-ID-10265639 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10265639
Market Overview:
Global Needle-Free Injection System Market Size study, by Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors) By Technology (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors) By Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors) By Usability ( Disposable Needle-Free Injectors, Reusable Needle-Free Injecto
Global Needle-Free Injection System Market is valued approximately USD 12 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.50% over the forecast period 2019-2026. Needle free injection system are type pf medical injection syringe used to deliver medication into the patient’s body without piercing the skin without piercing the skin with the conventional needles. These needles free injection system technology is gaining tracking as this eliminates the skin hazards and problems of bleeding or bruising. Growing prevalence of chronic diseases and lifestyle disorder are key driving forces of the needle free injection systems market growth. For instance, diabetic patients requiring regular glucose monitoring use needles that increases the risk of pain and infection among the individual. Use of needle free devices offer painless delivery and also reduce the risk of infection. Thus, rising number of diabetic patients worldwide is projected to boost the demand for needle free injection system market. Apart from this, Major factors driving the growth of this market include increasing incidence of communicable disease due to needle stick injuries, increasing demand for self-injection devices. Furthermore, rising demand for biosimilars and vaccination, advantages of drug delivery technology is expected to create significant growth opportunity in the market over the forecast period. However, high cost of development impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Needle-Free Injection System market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing prevalence of chronic diseases and technological advancements. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as favorable reimbursement policies, increasing healthcare infrastructure would create lucrative growth prospects for the Needle-Free Injection System market across Asia-Pacific region.
Major market player included in this report are:
Antares Pharma, Inc.
Endo International PLC
Pharmajet
Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.)
Medical International Technology, Inc. (MIT)
Injex Pharma AG
National Medical Products, Inc.
Valeritas, Inc.
European Pharma Group
Penject Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Liquid-Based Needle-Free Injectors
Projectile/Depot-Based Needle-Free Injectors
Powder-Based Needle Free Injectors
By Technology:
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
By Product:
Fillable Needle-Free Injectors
Prefilled Needle-Free Injectors
By Usability:
Disposable Needle-Free Injectors
Reusable Needle-Free Injectors
By Site of Delivery:
Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors
By Application:
Vaccine Delivery
Insulin Delivery
Oncology
Pain Management
Other Applications
By End User:
Hospitals and Clinics
Home Care Settings
Research Laboratories
Pharmaceutical and Biotechnological Companies
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Needle-Free Injection System Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Endo International PLC
Pharmajet
Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.)
Medical International Technology, Inc. (MIT)
Injex Pharma AG
National Medical Products, Inc.
Valeritas, Inc.
European Pharma Group
Penject Corporation
Related Reports
Proof of Quality & Reliability
